Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Miele

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Neuroimmunology|March 30, 2023
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumabGianmarco Abbadessa, Giuseppina Miele, Paola Cavalla, et al.
Frontiers in Psychology|May 16, 2020
Online Validation of a Battery of Questionnaires for the Assessment of Family Functioning and Related FactorsLuigi Lavorgna, Marialaura Di Tella, Giuseppina Miele, et al.
Acta Neurologica Belgica|October 2, 2019
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activityGabriella Santangelo, Marida Della Corte, Maddalena Sparaco, et al.
Journal of Clinical Medicine|June 26, 2025
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic ComplicationsElisabetta Maida, Paola Caruso, Simona Bonavita, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2021
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case-control studyGianmarco Abbadessa, Giuseppina Miele, Andrea Di Pietro, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center studyGiuseppina Miele, Gianmarco Abbadessa, Paola Cavalla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 25, 2024
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8<sup>+</sup> T-Cell Proliferation in Patients With Multiple SclerosisGianmarco Abbadessa, Maria Teresa Lepore, Sara Bruzzaniti, et al.
European Journal of Medical Genetics|November 5, 2022
Hydranencephaly in CENPJ-related Seckel syndromeClaudia Cuccurullo, Giuseppina Miele, Gianluca Piccolo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2021
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemicDario Ricciardi, Silvia Casagrande, Francesco Iodice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 22, 2024
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learningElisabetta Maida, Gianmarco Abbadessa, Eleonora Cocco, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Neuroimmunology|March 30, 2023
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumabGianmarco Abbadessa, Giuseppina Miele, Paola Cavalla, et al.
Frontiers in Psychology|May 16, 2020
Online Validation of a Battery of Questionnaires for the Assessment of Family Functioning and Related FactorsLuigi Lavorgna, Marialaura Di Tella, Giuseppina Miele, et al.
Acta Neurologica Belgica|October 2, 2019
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activityGabriella Santangelo, Marida Della Corte, Maddalena Sparaco, et al.
Journal of Clinical Medicine|June 26, 2025
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic ComplicationsElisabetta Maida, Paola Caruso, Simona Bonavita, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2021
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case-control studyGianmarco Abbadessa, Giuseppina Miele, Andrea Di Pietro, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center studyGiuseppina Miele, Gianmarco Abbadessa, Paola Cavalla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 25, 2024
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8<sup>+</sup> T-Cell Proliferation in Patients With Multiple SclerosisGianmarco Abbadessa, Maria Teresa Lepore, Sara Bruzzaniti, et al.
European Journal of Medical Genetics|November 5, 2022
Hydranencephaly in CENPJ-related Seckel syndromeClaudia Cuccurullo, Giuseppina Miele, Gianluca Piccolo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2021
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemicDario Ricciardi, Silvia Casagrande, Francesco Iodice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 22, 2024
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learningElisabetta Maida, Gianmarco Abbadessa, Eleonora Cocco, et al.
Pageof 5